Plain-English translation of NCT06804161 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether a medication called an inhibitor can help people with high blood pressure avoid serious heart problems. Doctors already prescribe this type of medication for diabetes and heart failure, and early research suggests it may also lower blood pressure and protect the heart in other ways. This large study will see whether this medication should become a standard treatment for high blood pressure.
Even when people take blood pressure medications, many still suffer heart attacks or strokes because the damage from high blood pressure continues. This medication works in new ways beyond just lowering numbers, so researchers want to confirm whether it can truly prevent these serious heart events.
You likely qualify if…
You likely don't qualify if…
You will take either the new medication or a placebo pill once daily as part of your regular routine. You'll attend clinic visits to have your blood pressure checked, blood tests done to monitor your kidneys and liver, and you'll be followed to see whether you experience any heart-related events. The study involves about 3,000 people, so it will take time to gather enough information to know if this treatment works.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Germany